(Q45374296)

13 December 2017

title

Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein (English)

1 reference

13 December 2017

7

Quanjiao Chen

1 reference

13 December 2017

Lina Guo

1

1 reference

13 December 2017

Mei Zheng

2

1 reference

13 December 2017

Yahong Ding

3

1 reference

13 December 2017

Dongmei Li

4

1 reference

13 December 2017

Zhongdong Yang

5

1 reference

13 December 2017

Haiming Wang

6

1 reference

13 December 2017

Zhiwei Sui

8

1 reference

13 December 2017

Fang Fang

9

1 reference

13 December 2017

Ze Chen

10

1 reference

13 December 2017

publication date

22 July 2010

1 reference

13 December 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Virology

1 reference

13 December 2017

volume

155

1 reference

13 December 2017

issue

11

1 reference

13 December 2017

page(s)

1765-1775

1 reference

Influenza: lessons from past pandemics, warnings from current incidents.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

A one-size-fits-all flu vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Cell-mediated protection in influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

A universal epitope-based influenza vaccine and its efficacy against H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Intracellular neutralization of virus by immunoglobulin A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Intraepithelial cell neutralization of HIV-1 replication by IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Rectification of age-associated deficiency in cytotoxic T cell response to influenza A virus by immunization with immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

Interferon-induced Mx proteins in antiviral host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0756-3

10.1007/S00705-010-0756-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1020264964

0 references

1 reference